NCT01444378

Absolute Pro® MOMENTUM™

Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent Systems in the Treatment of Subjects With Atherosclerotic De Novo or Restenotic Lesions in the Native Superficial Femoral Artery and/or Native Proximal Popliteal Artery.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 141 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the safety and effectiveness of the Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent System for the treatment of subjects with atherosclerotic de novo or restenotic lesions in the native superficial femoral artery (SFA) and/or the native proximal popliteal artery (PPA). CAUTION: Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent Systems are investigational devices. Limited by Federal (U.S.) law to investigational use only.

Conditions

• Peripheral Artery Disease
• Peripheral Vascular Disease

Interventions

Type	Name	Description
DEVICE	Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systems	Stenting of the Superficial Femoral Artery (SFA) and/or proximal popliteal artery using either of these devices.

Timeline

• Start date: 2011-10-01
• Primary completion: 2014-12-01
• Completion: 2015-05-01
• First posted: 2011-09-30
• Last updated: 2017-06-06
• Results posted: 2017-06-06

Locations

1 site across 1 country: United States